Introduction of hydrophobic fluorescent lipid analogues into living cultured cells and their imaging therein by Tanhuanpää, Kimmo
INTRODUCTION OF HYDROPHOBIC FLUORESCENT
LIPID ANALOGUES INTO LIVING CULTURED CELLS
AND THEIR IMAGING THEREIN
Kimmo Tanhuanpää
Institute of Biomedicine
Department of Biosciences, Division of Biochemistry, Faculty of Science
University of Helsinki
Academic dissertation
To be presented, with the permission of the Faculty of Science, University of Helsinki, for
public criticisms in the lecture hall 2 of Biomedicum, Haartmaninkatu 8, Helsinki
on August 17th at 1 p.m.
Helsinki 2001
Supervised by:
Docent Pentti J. Somerharju, Ph.D.
Institute of Biomedicine
University of Helsinki
Reviewed by:
Docent Esa Kuismanen, Ph.D.
Division of Biochemistry,
Department of Biosciences University of Helsinki
And
Docent Vesa Olkkonen, Ph.D.
National Public Health Institute
Helsinki
Opponent:
Professor Peter Slotte
Department of Biochemistry and Pharmacy
Åbo Akademi University
ISBN 952-91-3559-9 (nid.)
ISBN 952-10-0030-9 (pdf)
Http://ethesis.helsinki.fi
Yliopistopaino
Helsinki 2001
To my father Unto (1947 – 2000)
and to my son Kaarlo (2000 -)
11. TABLE OF CONTENTS
1. TABLE OF CONTENTS ............................................................................................. 1
2. ABBREVIATIONS....................................................................................................... 3
3. LIST OF ORIGINAL PUBLICATIONS.................................................................... 4
4. INTRODUCTION ........................................................................................................ 5
5. REVIEW OF THE LITERATURE ............................................................................ 7
5.1. The structure and lipid composition of biological membranes............................ 7
5.1.1. Organization of biological membranes.............................................................. 7
5.1.2. Lipid composition of eucaryotic membranes...................................................... 8
5.1.3. Lipid synthesis and transport  in eukaryotic cells .............................................. 8
5.2. Short-chain fluorescent lipids.................................................................................. 9
5.3. Pyrene lipids............................................................................................................ 10
5.4. Previously used cell labeling methods .................................................................. 16
5.5. Cyclodextrins .......................................................................................................... 17
5.6. Imaging of fluorescent lipids in cells..................................................................... 17
6. AIMS OF THE PRESENT STUDY.......................................................................... 19
7. EXPERIMENTAL PROCEDURES ......................................................................... 20
7.1. Lipids and other reagents. ..................................................................................... 20
7.2. Assay of cyclodextrin-mediated lipid transfer and binding. .............................. 20
7.3. Cell Culture............................................................................................................. 21
7.4. Incubation of cells with cyclodextrins and donor vesicles. ................................. 21
7.5. Fluorescence imaging ............................................................................................. 22
7.6. Fluorescence and IR spectrometry. ...................................................................... 22
7.7. Other methods ........................................................................................................ 23
8. RESULTS .................................................................................................................... 24
8.1. Interbilayer transfer of pyrene phospholipids by cyclodextrins........................ 24
8.1.1. Transfer of pyrene phospholipids between vesicles ......................................... 24
8.1.2. Comparison of different cyclodextrins ............................................................. 25
8.1.3. Effect of pyrene phospholipid acyl chain length .............................................. 26
8.1.4. Effect of lipid head group and backbone structure .......................................... 26
8.2. Binding of pyrene lipids by -cyclodextrins ......................................................... 26
28.2.1. Thermodynamics of the complex formation ..................................................... 28
8.2.2. Spectroscopic characterization of pyrene PC/ -cyclodextrin complex............ 28
 -cyclodextrin-mediated transfer of fluorescent lipids from vesicles to cultured
cells .................................................................................................................................. 29
8.3.1. Transfer assays................................................................................................. 29
8.3.2. Mechanism of cell labeling............................................................................... 30
8.3.3. Effect of -cyclodextrin on cell viability ........................................................... 32
8.4. Fluorescence imaging of pyrene lipids in cells..................................................... 32
8.4.1. Prevention of photobleaching .......................................................................... 32
8.4.2. Effect of oxygen on cell viability ...................................................................... 34
8.4.3. Elimination of background fluorescence.......................................................... 34
8.4.4. Selective imaging of pyrene lipids in the plasma membrane. .......................... 35
8.4.5. Pyrene fluorescence quenching in model membranes...................................... 35
8.5. Hydrophobicity-dependent transfer of dipyrenyl PS from plasma membrane to
mitochondria. .................................................................................................................. 37
9. DISCUSSION.............................................................................................................. 38
9.1. Transfer of pyrene phospholipids by cyclodextrins ............................................ 38
9.1.1. Mechanism of -CD -mediated phospholipid transfer ..................................... 38
9.1.2. Characteristics of the pyrene PC/ -cyclodextrin-complex............................... 39
9.1.3. Cyclodextrins as carriers for other lipids. ....................................................... 39
 -cyclodextrin-mediated labeling of cells with hydrophobic fluorescent
phospholipids. ................................................................................................................. 41
9.3. Improved imaging of pyrene labeled lipids in living cells .................................. 42
9.3.1. Prevention of  photobleaching of pyrene lipids in cells ................................... 42
9.3.2. Correction for autofluorescence and light scattering ...................................... 42
9.3.3. Selective imaging of the plasma membrane and its leaflets ............................. 43
9.4. Advantages of hydrophobic lipid analogues in lipid trafficking studies ........... 44
10. CONCLUSIONS..................................................................................................... 46
11. ACKNOWLEDGEMENTS................................................................................... 47
12. REFERENCES ....................................................................................................... 48
32. ABBREVIATIONS
10:0-Pyr10PC sn-1-decanoyl, 2-pyrenedecanoyl-phosphatidylcholine
16:0-PyrnPC sn-1-palmitoyl,2-pyrenylacyl-phosphatidylcholine
(n = number of aliphatic carbons in the pyrenylacyl chain)
BHK-21 Baby Hamster Kidney cells
BODIBY12-PC 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-
indacene-3-dodecanoyl)-sn-glycero-3-phosphocholine
BODIPY12-PE 1-hexadecanoyl,2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-
indacene-3-dodecanoyl)-sn-glycero-3-phosphoethanolamine
BODIPY12-SM sn-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-
dodecanoyl)-sphingosylphosphorylcholine
CD cyclodextrin
-CD -cyclodextrin
CE--CD carboxyethyl--cyclodextrin
DiPyrnPC sn-1,2-pyrenylacyl-phosphatidylcholine (n = number of aliphatic
carbons in the pyrenylacyl chain)
DOPE sn-1, 2-dioleyl-phophatidylethanolamine
ER endoplasmic reticulum
FA fatty acid
HF Human fibroblast cells
LDH lactate dehydrogenase
MEM Minimum Essential Medium
MonoPyrnPC sn-1-acyl, 2-pyrenylacyl-phosphatidylcholine
NBD12PS 2-(12-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl-1-
hexadecanoyl-sn-glycero- 3-phosphoserine
NBD6PC 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-
hexadecanoyl-sn-glycero- 3-phosphocholine
PC phosphatidylcholine
PE phosphatidylethanolamine
PG phosphatidylglycerol
PI phosphatidylinositol
POPA  sn-1-palmitoyl, 2-oleoyl-phosphatidic acid
POPC sn-1-palmitoyl, 2-oleoyl-phosphatidylcholine
PS phosphatidylserine
PyrnPC 16:0-pyrenylacyl-phosphatidylcholine (n = number of aliphatic car-
bons in the acyl chain)
PyrPC  pyrenylacyl-phosphatidylcholine
PyrPL  pyrene-labeled phospholipid
SM sphingomyelin
TNP-LPE N-trinitrophenyl-lysophosphatidylethanolamine
TNP-PE N-trinitrophenyl-phosphatidylethanolamine
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54.  INTRODUCTION
Eukaryotic cells contain multiple membrane-bound compartments whose special-
ized functions require distinct protein and lipid compositions. Assembly of a proper set of
proteins and lipids into each compartment requires a three-step process involving (1) the
biosynthesis of proteins and lipids, (2) selective transport of proteins and lipids across a bi-
layer, (3) selective transport of proteins and lipids between different membrane compart-
ments. Experimental work over the last 15 years has brought us detailed knowledge about
the molecular mechanisms responsible for intra- and intercompartmental protein transport,
but knowledge concerning lipid trafficking is less detailed.
Most phospholipids are synthesized in the endoplasmic reticulum (ER), but are
abundant in all organelle membranes (Dennis and Kennedy, 1972). Efficient transport of
those phospholipids from ER to other organelles must take place. There are several mecha-
nisms that could account for this transfer, i.e., vesicle traffic, spontaneous or protein-
assisted diffusion via the cytoplasm, or diffusion via membrane (hemi)fusion sites (re-
viewed in Voelker, 1991; van Meer and van Genderen, 1994). The relative contributions of
these various transport mechanisms have not been established. It is also unknown how the
intracellular trafficking of phospholipids is controlled so that the different membranes can
maintain their distinct lipid compositions. A major reason for this lack of knowledge is that
it is very difficult to follow the trafficking of phospholipids inside the cell. For example,
immunolocalization, which has played a key role in resolving the sorting and transport
mechanisms of proteins, cannot be applied because phospholipids are generally poor anti-
gens, most (glycero)phospholipids are abundant in all membranes, and because it is not
possible to obtain stoichiometric complex formation due to the large size of the antibody
molecule.
To circumvent the tracing problem, short-chain fluorescent (C6-NBD) lipids were
introduced by Pagano and co-workers (reviewed in Pagano and Sleight, 1985; Rosenwald
and Pagano, 1993). However, due to their hydrophilicity these lipids can distribute sponta-
neously between all accessible membrane surfaces (Pagano et al., 1983). Thus their use is
questionable when one studies intracellular trafficking of lipids having access to the cyto-
plasmic leaflet of organelle membranes, which is the case with most glycerophospholipids.
Accordingly, fluorescent derivatives with hydrophobicity similar to that of endogenous
phospholipids need to be employed to obtain relevant information on intracellular traffick-
ing of the latter. Unfortunately, such derivatives are quite hard to introduce into cells be-
6cause of their hydrophobicity. There are several, most often vesicle fusion based, methods
to achieve this but none of them are fully satisfactory.
To follow trafficking of fluorescent lipids in cells, one must be able to quantitatively
and selectively image organelle membranes. This is complicated by several factors like
background fluorescence and scattering from the optics and the medium and photobleach-
ing of the fluorophore. Also cellular autofluorescence deriving mainly from NAD/NADH+,
flavins and lysosomal residues (Schnell et al., 1999) can be significant, particularly at low
probe concentrations. Typically, an off-focus image or an image obtained from a cell-free
area is subtracted to correct for the background signal (Wolf, 1998). These methods, how-
ever, are not always satisfactory, as they do not properly account for the uneven distribution
of cellular autofluorescence.
The aim of this study was to address the aforementioned problems. Several methods
allowing introduction and quantitative imaging of hydrophobic pyrene-labeled phospho-
lipids in cells were developed.
75. REVIEW OF THE LITERATURE
5.1. The structure and lipid composition of biological membranes
5.1.1. Organization of biological membranes
Most biological membranes are extremely complex structures consisting of hun-
dreds or thousands different molecules. The present view of organization of these mem-
branes is based on the fluid-mosaic model from year 1972 (Singer and Nicolson, 1972). In
this model phospholipids together with other lipids form a fluid bilayer where the incorpo-
rated proteins and the lipid themselves are free to diffuse laterally. Accordingly, the mem-
brane components would be more or less randomly organized in the membrane. However,
since then, experimental and theoretical data indicating that membranes are not laterally
homogenous has been accumulated (Simons and Ikonen, 1997). Instead domains having
distinct lipid and protein compositions exist. In particular, evidence for membrane domains
enriched in sphingolipids, cholesterol and certain proteins has been obtained (Brown and
Rose, 1992). The feasibility of domain segregation in biological membranes is strongly
supported by the fact that domains have been detected in model membranes consisting of
different phospholipid species or of a phospholipid and cholesterol (Sankaram and Thomp-
son, 1991; Chong et al., 1994; Virtanen et al., 1995).
The factors driving domain formation in natural membranes are poorly understood
at present. A commonly accepted model is that certain, more rigid lipids, like cholesterol
and sphingolipids, prefer to associate with each other, thus resulting in formation of do-
mains rich in these lipids (Simons and Ikonen, 1997; Rietveld and Simons, 1998; Brown
and London, 1998). This model is largely based on the finding that treatment of cells with
certain detergents at low temperature did not fully dissolve the membranes, but left frag-
ments consisting mainly of cholesterol, sphingomyelin and glycosphingolipids as well as
certain proteins (Brown and Rose, 1992). Later experiments have provided more direct evi-
dence for the existence of cholesterol/sphingolipid-rich domains in cell membranes (e.g.
Pralle et al., 2000). The formation of such domains is probably driven by the complemen-
tary geometrical shapes of the sphingolipid and cholesterol molecules as well as by inter-
molecular hydrogen bonding (Slotte, 1999).
8On the other hand, there is now considerable evidence from model membrane stud-
ies that in multicomponent lipid bilayers the different components tend to adopt a regular,
rather than random lateral distribution. This phenomenon (reviewed in Somerharju et al.,
1999), also referred to as superlattice formation, is very intriguing because it means that
there are a number of “critical” compositions which are predicted to be energetically more
favorable than the other, intervening compositions. Because of this property, such critical
compositions could play a central role in the regulation of the lipid composition of cellular
membranes (Virtanen et al., 1998). Notably, the superlattice model also predicts that do-
mains of different composition (i.e., different stoichiometry of the components) can be pre-
sent in membranes.
5.1.2. Lipid composition of eucaryotic membranes
The main lipid components in eucaryotic cell membranes are glycerophospholipids,
steroids and sphingolipids. The most abundant glycerophospholipids are phosphatidylcho-
line (PC) and phosphatidylethanolamine (PE) which account for 50 to 70 % of the lipids in
most membranes. Other common glycerophospholipids are phosphatidylserine (PS) and
phosphatidylinositol (PI). The main sterol in mammalian cells is cholesterol. Sphingolipids
are a group of lipids that have a ceramide backbone consisting of a sphingoid base and a
fatty acid that is amide-linked to the 2-position of the base. The major sphingolipid is
sphingomyelin (SM) and other sphingolipids include a large variety of glycosphingolipids
like glucosylceramide and galactosylceramide (van Meer and van Genderen, 1994). Differ-
ent cellular membranes have characteristic lipid compositions. The plasma membrane is
rich in SM, cholesterol and PC, the ER is rich in PC and PI and all of cardiolipin is in mito-
chondria. In BHK cells about 27 % of total lipids and 17 % of phospholipids are in the
plasma membrane. 67 % of total cellular SM and PS are in the plasma membrane, and of
these most of the SM is in the outer leaflet and all of the PS is on the inner leaflet. In these
cells the ER accounts for 28 %, mitochondria for 16 % and lysosomes for 14 % of total
lipids (Allan, 1996).
5.1.3. Lipid synthesis and transport  in eukaryotic cells
Glycerophospholipids are synthesized in the endoplasmic reticulum and SM synthe-
sis occurs in the lumenal leaflet of the Golgi, but they are abundant in all organelle mem-
branes (Dennis and Kennedy, 1972). In addition, lipids are not always synthesized in the
9membranes where their concentration is highest, e.g. cholesterol synthesis occurs in the ER
but cholesterol is concentrated in the plasma membrane. Accordingly, efficient transport of
the lipids from their sites of synthesis to other organelles must take place. There are several
mechanisms that could account for this transfer, i.e., vesicle traffic, spontaneous or protein-
assisted diffusion via the cytoplasm, or diffusion via membrane (hemi)fusion sites (re-
viewed in Voelker, 1991; van Meer and van Genderen, 1994). Lipids are transported with
proteins along the vesicle transport pathways from ER to Golgi to plasma membrane or en-
dosomes. From plasma membrane they are transported to endosomes, back to Golgi and to
lysosomes. There is a concentration gradient along the exocytotic transport pathway from
the ER to plasma membrane where enrichment of SM, glycosphingolipids, and cholesterol
is observed at the cost of PC and PI. Monomeric diffusion via aqueous phase is a slow pro-
cess for most lipids, in the order of hours (cholesterol) to weeks (glycosphingolipids) be-
tween lipid vesicles. This transfer can be dramatically enhanced by close apposition of cel-
lular membranes. In cells there are also lipid transfer proteins that enhance lipid transfer in
vitro, but their role in lipid transport processes in vivo is unclear. Of the lipid transport pro-
cesses, lipid diffusion in the plane of the membrane is the fastest process. It is relatively
insensitive to lower temperatures. Some membranes, like the inner and outer mitochondrial
membranes, may be connected through (temporary) membrane continuities, which would
allow fast lipid diffusion between these membranes. The relative contributions of these
various transport mechanisms have not been established. It is also unknown how the intra-
cellular trafficking of phospholipids is controlled so that the different membranes can
maintain their distinct lipid compositions.
5.2. Short-chain fluorescent lipids
Short-chain fluorescent (6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-
hexadecanoyl (NBD6) labeled lipids have been shown to be very useful in studying sphin-
golipid trafficking (van Meer and Holthuis, 2000; Koval and Pagano, 1991; Hoekstra and
Kok, 1992). To name some examples, NBD6-GlcCer and NBD6-SM labeling has been used
to study segregation of glucosylceramide and sphingomyelin in the apical to basolateral
transcytotic route in HepG2 cells (van IJzendoorn et al., 1997). NBD6-ceramide has been
used to study biogenesis of bile canaliculi in hepatic cells (Zaal et al., 1994) and trafficking
of sphingolipids in differentiated versus undifferentiated HT29 cells (Babia et al., 1993).
NBD-lipids have been used more rarely to study glycerophospholipid trafficking.
One reason for this is that at the physiological temperature short-chain NBD-phospholipids
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are rapidly degraded in mammalian cells (Pagano et al., 1983; Sleight and Pagano, 1985;
Sleight and Pagano, 1984). This might be due to the looping conformation of the labeled
chain that renders NBD-lipids targets for some cellular phospholipases. This looping is
caused by the NBD-moiety being so hydrophilic that regardless of the length of the con-
necting acyl chain, the NBD-group is located close to the hydrocarbon – water interface
(Chattopadhyay and London, 1987; Wolf et al., 1992; Huster et al., 2001). An even more
serious limitation of these lipids is that they can distribute spontaneously between all acces-
sible membrane surfaces due to their hydrophilicity (Pagano et al., 1983).
Besides NBD also boron dipyrromethene difluoride (BODIPY) labeled lipids have
been used in lipid trafficking studies. The BODIPY-fluorophore has a higher fluorescence
yield and it is more photostable than NBD. It is also less polar than NBD and is therefore
propably better anchored in the membrane bilayer (Bai and Pagano, 1997). BODIPY-
labeled lipids have a molar density -dependent fluorescence emission maximum that makes
it possible to differentiate membranes containing high and low concentrations of the fluo-
rescent probe (Pagano et al., 1991). However, BODIPY-lipids are also hydrophilic enough
to distribute spontaneously between all accessible membrane surfaces (see table 1 in I).
There are several other common fluorescent probes. 3,3’-dioctadecyl-
idocarbocyanine (DiI) is hydrophobic but it also is positively charged, and does not resem-
ble any natural lipid species (Pitas et al., 1981). 5-dimethylmethylaminonaphtene-1-
sulfonyl (dansyl) is hydrophilic and like NBD it is located close to the hydrocarbon – water
interface (Bartlett et al., 1997). Also antraoyloxy- and diphenylhexatriene fatty acids can be
used but they mimic natural lipids less well than pyrene lipids (see below; Naylor et al.,
1991).
5.3. Pyrene lipids
Pyrene labeled phospholipids (PyrPLs) represents another type of fluorescent lipid
derivatives that can be used to study lipid traffic (Fig. 1). There are several advantages in
using pyrene lipids. First, pyrene lipids form concentration-dependent excited-state pyrene
dimers, i.e., excimers. At low concentrations, pyrene emits only monomer fluorescence at
370-420 nm. However, when the concentration of the fluorophore increases, the probability
of collisions between these excited monomers and ground state pyrene molecules increases,
which leads to formation of excimers that emit in the 430-550 nm region (Fig. 2). The ex-
cimer formation provides a convenient tool for monitoring many interesting phenomena
(see below).
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Fig. 1. Structures of 16:0-
Pyr10PC (left) and DiPyr10PC
(right). In the monopyrene lipids
used in this study (16:0-PyrnPXs
and 10:0-PyrnPXs), only the sn-2
acyl chain contains the pyrene
label, the sn-1 chain is saturated
and contains either 16 or 10 car-
bons. The length of the pyrenyla-
cyl chain (n) varied from 4 to 14
carbons with two methylene unit
intervals. In the dipyrene lipids
(DiPyrnPXs) both the acyl chains
contain a pyrene moiety linked to
the terminal methylene unit. The
length of the pyrenylacyl chains
(n) varied from 4 to 14 carbons
with two methylene unit intervals.
Variation of the acyl chain length
of DiPyrnPXs by two methylene
units has a much larger relative
effect on the lipid hydrophobicity
than in the case of 16:0-PyrnPXs,
since both acyl chains are ex-
tended.
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Fig. 2. Normalized emission spectra for a mono- and dipyrene lipid. 16:0-Pyr4PC
in -CD cavity emits mostly monomer fluorescence (thin line) and DiPyr4PC in -CD cavity
emits mostly excimer fluorescence (thick line). For details see II.
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Second, the pyrene moiety is hydrophobic and thus does not significantly alter the
conformation of the parent lipid (Sassaroli et al., 1995) unlike more polar fluorophores like
NBD (Wolf et al., 1992; Chattopadhyay and London, 1987; Huster et al., 2001) and Dansyl
(Bartlett et al., 1997) do. It is also notable that pyrene does not significantly increase the
effective size of a phospholipid molecule in a lipid monolayer (Somerharju et al., 1985).
Third, PyrPLs mimic well natural phospholipids. They are good substrates for intra-
cellular lipid transfer proteins (Somerharju et al., 1987; van Paridon et al., 1988; van Am-
erongen et al., 1989; Szolderits et al., 1989). 1,2-dipyrenebutanoyl derivatives of phospha-
tidylcholine, -ethanolamine, and -serine and phosphatidic acid (DiPyr4PC, -PE, -PS, and -
PA, respectively) have similar metabolism and transbilayer movement as the corresponding
natural lipids (Kasurinen and Somerharju, 1995). All of them are efficiently incorporated
into plasma membrane via spontaneous diffusion from donor vesicles at 8 oC. At this tem-
perature endocytosis is negligible and the PC-analogue is restricted to the outer leaflet of
the plasma membrane. Conversely the PS- and PE-analogues move through plasma mem-
brane via the aminophospholipid translocase and label intracellular structures. At 8 oC a
considerable fraction of DiPyr4PA is metabolized to the corresponding diglyceride and tri-
glyceride in one hour. At 37 oC, DiPyr4PA is metabolized to DiPyr4PC, and after an 8-h in-
cubation it represents 90% of total DiPyr4 lipids. DiPyr4PS is converted to DiPyr4PE with
an apparent half time of 3 h, by decarboxylation in the mitochondria as isolated mitochon-
dria can decarboxylate all PyrPS species (Jasinska et al., 1993). In contrast to the PA and
PS derivatives, no head group modification of either DiPyr4PC or DiPyr4PE has been re-
ported. Pyrenyl fatty acids (PyrxFA) introduced to cell growth medium are incorporated to
cellular lipids (Kasurinen and Somerharju, 1992). This incorporation is more efficient than
what it is with antraoyloxy, dansyl, diphenylhexatriene or NBD fattyacids (Pownall and
Smith, 1989; Naylor et al., 1991). The length of the acyl chain affects the efficiency of in-
corporation as well as distribution of the label between lipid species. PyrxFAs can be di-
vided into two groups: 1) the short-chain ones including the pyrene butyrate and hexanoate
derivatives, which show only modest incorporation to phospholipids and negligible labeling
of triglycerides and cholesterol esters, and 2) the long-chain PyrxFAs including pyrene oc-
tanoate, decanoate, dodecanoate, and myristate derivatives. The longer ones incorporate
efficiently to both phospholipids, mainly PC and  PE, and neutral lipids, i.e. di- and triglyc-
erides and cholesterol esters. The longer PyrxFAs are esterified preferentially to the sn-1
position of the glycerol moiety of PC and PE while the shorter ones are found exclusively
in the sn-2 position indicating that the longer PyrxFAs mimic natural saturated fatty acids
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whereas the shorter ones may be recognized as polyunsaturated fatty acids by the acylating
enzymes. PyrxFAs are shortened, probably by -oxidation in peroxisomes, down to pyrene
butyrate.
The fourth advantage of using pyrene lipids is that several systematically constructed
sets that cover the hydrophobicity range of natural lipids are available (Somerharju et al.,
1987; van Paridon et al., 1988). This helps to draw conclusions regarding the mechanism of
lipid transfer in vivo, (see Heikinheimo and Somerharju, 1998).
In microscopy the pyrene lipids are somewhat more problematic than NBD or
BODIPY lipids because they require excitation in the UV range, i.e. at 345 nm. Many mi-
croscopes are not optimized for this wavelength. The pyrene monomer emission peaks at
378 and 395 nm are also not optimal for most microscopes, but this can be circumvented by
using dipyrene lipids and monitoring excimer emission at 450-500 nm. In principle it is
possible to microscopically map lipid concentration gradients in cellular membranes with
excimer/monomer -ratio imaging (Dix and Verkman, 1990).
Pyrene lipids have been frequently used to study spontaneous or protein-mediated
lipid transport (Ohnishi et al., 1994; Via et al., 1985; Roseman and Thompson, 1980;
Pownall and Smith, 1989; Somerharju et al., 1987; Rao et al., 1997; Rajaram et al., 1994)
and particle fusion (Stegmann et al., 1993). Also a variety of membrane-related phenomena
including lateral (Galla et al., 1979; Eisinger et al., 1986; Sassaroli et al., 1990) and trans-
verse (Pownall and Smith, 1989) diffusion of lipids, lateral organization of membranes
(Galla and Sackmann, 1974; Hresko et al., 1986; Somerharju et al., 1985; Tang and Chong,
1992) and phospholipid conformation (Eklund et al., 1992) have been studied. Phospholi-
pase activity has been studied with dipyrene lipids by measuring the excimer/monomer -
ratio which decreases when the lipid is hydrolyzed (Hendrickson, 1994). Alternatively, py-
rene lipids that have a covalently attached quencher group, e.g. trinitrophenyl have been
used. Such a lipid has negligible fluorescence when intact, but hydrolysis of the lipid causes
separation of the fluorophore and the quencher which causes an increase in the fluorescence
intensity (Thuren et al., 1988; Zandonella et al., 1995; Duque et al., 1996).
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5.4. Previously used cell labeling methods
Short-chain fluorescent lipids can be introduced into cells simply by incubating the
cells with donor vesicles containing the fluorescent lipid. The lipid moves relatively rapidly
to the cells via spontaneous diffusion. For example, when human fibroblast (HF) cells are
co-incubated with phospholipid vesicles containing DiPyr4PC at 8 oC, a considerable
amount of fluorescent lipid is incorporated into the cells, but 10-fold less of the vesicle
marker, [3H]cholesteryl oleate is associated with the cells (Kasurinen and Somerharju,
1995). On the other hand, long-chain fluorescent lipids cannot be introduced into cells in
this way because of their hydrophobicity. Several methods for introduction of such lipids to
cells have been reported. Van Meer and Simons (1983) developed a method where MDCK
cells are infected with fowl plague or influenza N virus. After a 4 h incubation, the hemag-
glutinin spike glycoprotein of the virus is present on the plasmamembrane. Then lipid vesi-
cles containing the fluorescent lipid, egg PC, cholesterol and hemagglutinin receptor are
bound to the cells at 0 oC. The vesicles are then fused to the cells at pH 5.3, 37 oC for 30 s.
This gives approximately 50 % fusion. The problem with this system is that the infection
shuts off the host cell protein synthesis. This limits the time span of the experiment and
such a drastic alteration of cellular metabolism may well disturb the normal structure of
cellular membranes. The problems of infection can be circumvented by transfecting the
hemagglutinin gene to the cells (Danieli et al., 1996). This, however, is quite tedious and
the expression of a foreign protein on plasma membrane may also perturb the membrane
organization. Another method by van Meer and co-workers (1980) uses phosphatidylcho-
line-specific exchange proteins from rat or beef liver that are used to transfer PC between
vesicles and cells. This requires a relatively large amount of the precious transfer protein,
which makes routine cell labeling with this method impractical.
Fusogenic vesicles consisting of a cationic amphiphile like dioleoyloxy-propyl-
trimethylammonium chloride (DOTMA) and DOPE can also be used to transfer nonex-
changeable lipids to cultured cells (Leventis and Silvius, 1990). This method is more often
used in cell transfection. The fusogenic vesicles unfortunately introduce a relatively large
amount of cytotoxic lipids to cells and may cause pore formation in membranes (van der
Woude et al., 1995).
As noted above, cells can be labeled by incubating them with a labeled fatty acid.
This is a non-specific method, i.e., several lipid classes are labeled simultaneously
(Kasurinen and Somerharju, 1995). A low concentration of Pluronic F127 detergent in the
labeling medium has been shown to enhance cell labeling. Usually this method is used to
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load calcium indicators to cells (Poenie et al., 1986), but it has also been used to introduce
bis-pyrene-propane to cells (Dix and Verkman, 1990).
5.5. Cyclodextrins
Cyclodextrins (CDs) are doughnut-shaped cyclic polymers consisting of 6 (-CD),
7 (-CD), 8 (-CD) or more glucose (-(14) glucopyranose) units. CDs originate from
enzymatic degradation of starch by CD-glucano-transferase. They are capable of solubiliz-
ing hydrophobic molecules in aqueous media due to the hydrophobic character of their in-
ternal cavity. The cavity is hydrophobic because it is lined with skeletal carbons and ethe-
real oxygens of the glucose residues while all hydrophilic groups are on the outer surface of
the molecule (Szejtli, 1988). Cyclodextrins have many pharmacological applications as
they can be used to enhance drug solubility and delivery (Szejtli, 1988; Loftsson and Brew-
ster, 1996). More recently cyclodextrins have become popular tools among cell biologist as
well. -CD and its derivatives have been widely used to manipulate the cholesterol content
of cultured cells (Klein et al., 1995; Christian et al., 1997) as well as to assess cholesterol
transport to the cell surface (Neufeld et al., 1996; Heino et al., 2000). -Cyclodextrin de-
rivatives mediate efficient transfer of cholesterol between lipid vesicles and cells in culture,
but so far cyclodextrins have not been used to introduce hydrophobic fluorescent phospho-
lipid derivatives into cultured cells.
5.6. Imaging of fluorescent lipids in cells
To accurately study trafficking of fluorescent lipids in cells one needs to perform
quantitative imaging of the fluorescent lipid in cells. This is very difficult to achieve, for
several reasons. First of all, most fluorophores photobleach rapidly under the intense exci-
tation light of the microscope. The rate of photobleaching also varies from one organelle to
another (Benson et al., 1985). These issues seriously hamper quantitative imaging. The
problem is particularly serious when a series of images have to be obtained from the same
field of view (Tsien and Waggoner, 1995). Although the rate of photobleaching can be sig-
nificantly reduced by adding certain chemicals like n-propyl gallate (Giloh and Sedat,
1982) or commercial antifading agents (Florijn et al., 1995), this usually requires that the
cells have been pretreated with an aldehyde fixative such as paraformaldehyde. This chemi-
cally modifies the head groups of the aminophospholipids PE and PS (Kenney, 1984).
Since these lipids account for up to 80 % of the total phospholipids in the inner leaflet of
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the plasma membrane (Allan, 1996), the head group modification is likely to lead to major
rearrangements of the lipid bilayer. Accordingly, fixing should be avoided when studying
lipid organization and transport in cellular membranes.
Secondly, it is difficult to properly correct for the background caused by cellular
autofluorescence and light scattering. Simple subtraction of (i) an off-focus image, (ii) an
image of a cell-free area of the coverslip or (iii) an image obtained by spatial averaging
does not provide full correction since the spatial distribution of cellular autofluorescence is
typically uneven. This is particularly problematic when the concentration of the fluorescent
lipids is low. Low concentrations are desirable, however, to avoid fluorophore-induced
membrane perturbations.
Thirdly, selective imaging of an organelle membrane is often impossible due to the
contribution to the signal by the fluorophores located in another membrane in proximity.
Confocal microscopy and computational methods available for wide-field microscopes
(Agard et al., 1989; Brakenhoff et al., 1989) help here, but they do not fully resolve the
problem because of the limited resolution of microscope objectives in the z-direction. The
plasma membrane is particularly difficult to image selectively due to numerous endo- and
exocytotic vesicles in its close proximity.
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6. AIMS OF THE PRESENT STUDY
The main goal of this study was to develop methods allowing the use of hydropho-
bic pyrene labeled phospholipids and quantitative microscopic imaging to study intracellu-
lar phospholipid trafficking. More specifically, the aims were to elucidate:
1) Whether cyclodextrins can enhance interbilayer transfer of pyrene-labeled phos-
pholipids and, if so, what is the mechanism of transfer?
2) Can cyclodextrins be used to transfer pyrene and other fluorescent phospholip-
ids to living cells?
3) How can one optimize microscopic imaging of pyrene-labeled lipids in living
cells?
The methods developed were then used to study how the hydrophobicity (acyl chain
length) of pyrene labeled phosphatidylserine affects its intracellular location.
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7. EXPERIMENTAL PROCEDURES
7.1. Lipids and other reagents.
All unlabeled lipids were obtained from Avanti Polar Lipids (Alabaster, AL).
BODIPY12-PC, -PE and -SM as well as NBD12PC were supplied by Molecular Probes
Europe (Leiden, Netherlands). BODIPY-PC and -PE were repurified shortly before use by
HPLC on silica gel and BODIPY-SM on a reverse phase column. The pyrenylacyl glycero-
phospholipids were synthesized as described previously (Somerharju and Wirtz, 1982;
Somerharju et al., 1985). Pyrenyldecanoyl sphingomyelin was synthesized using the
method of Via et al. (1985). All labeled lipids were at least 99.5 % pure as determined by
HPLC. The CDs were obtained from Cyclolab (Budapest, Hungary). Trinitrophenyl-
lysophosphatidylethanolamine was prepared according to (van Duijn et al., 1985) as de-
scribed in [III]. All solvents used were of HPLC grade and were obtained from Merck
(Espoo, Finland), the cell culture media were obtained from Gibco (Paisley, England) and
all other chemicals from Sigma (St. Louis, MO).
7.2. Assay of cyclodextrin-mediated lipid transfer and binding.
The previously described fluorescence dequenching assays (Somerharju et al., 1987)
were employed to study the transfer and binding of pyrenyl lipids. The donor vesicles con-
sisted of a pyrenyl lipid, POPC and TNP-PE (0.2 : 45 : 5 nmol), while the acceptor vesicles
consisted of POPC and POPA (480 : 20 nmol). TNP-PE is a nontransferable quencher of
pyrene fluorescence. Transfer of the pyrenyl lipid molecules from quenched donor vesicles
to acceptor vesicles results in dequenching of pyrene fluorescence which is recorded. To
measure binding, quenched donor vesicles were titrated with a cyclodextrin solution and the
pyrene fluorescence intensity was recorded. All measurements were carried out at 25 C
unless otherwise noted. The association constant K for the complex formation was obtained
by fitting the following equation to the fluorescence data (II):
F = (F0 + F∞ * K * x z ) / (1 + K  * x z ) (1)
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F0 is the pyrene fluorescence intensity in the absence of -CD, F∞ is the fluores-
cence intensity at an infinite -CD concentration, x is the cyclodextrin concentration and z
is the -CD to PyrPC ratio in the complex.
The kinetics of complex formation were studied by rapidly mixing -CD solution
with quenched donor vesicles in a cuvette followed by recording the pyrene fluorescence
intensity with time. The complex formation appeared to consist of two kinetic processes
with different rate constants. The following equation was employed to obtain the rate con-
stants (II):
F = F0 + A1 * (1 - e – t / t1) + A2 * (1 - e – t / t2) (2)
F0 is the initial fluorescence, t is the time, t1 and t2 are the half times of the two ki-
netic processes and A1 and A2 are fitting parameters.
7.3. Cell Culture
Normal Human fibroblasts (GM08333) and BHK-21 cells were grown as previously
described (Kasurinen and Somerharju, 1995; Heikinheimo and Somerharju, 1998). For mi-
croscopy, the cells were plated on round 32-mm coverslips placed in home-built aluminum-
Teflon chambers. Before use, the coverslips were cleaned by treating them for 1 h at 50 C
with 1 M NaOH and 1 M HCl each, followed by washing with water and ethanol. After 1-2
hours of incubation at 37 C, the inoculum was removed and the attached cells were
washed, covered with normal growth medium and placed in the incubator. Labeling and
imaging were carried out the following day. This cultivation protocol considerably reduced
the amount of cell debris on the coverslips.
7.4. Incubation of cells with cyclodextrins and donor vesicles.
Cell monolayers were washed twice with CO2-independent minimal medium (I-
MEM), twice with PBS and then incubated at room temperature or 37 C in I-MEM con-
taining the donor vesicles with or without cyclodextrin. The CE--CD stock solution was
prepared in I-MEM and adjusted to pH 7.4 to avoid acidification of the incubation medium.
This adjustment somewhat reduced the efficiency of labeling but was necessary to avoid
harmful effects to cells, particularly at higher CE--CD concentrations. After the incuba-
tion, the cells were washed three times with I-MEM and then subjected to imaging or lipid
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extraction. For the latter, the cells were scraped into PBS, washed twice by centrifugation
and then extracted according to (Bligh and Dyer, 1959). The amount of cell-associated fluo-
rescent lipid was determined by measuring the pyrene (excimer) or BODIPY fluorescence
intensity of the extract. Extracts of non-incubated cells were used as blanks. Alternatively,
the amount of cell-associated fluorescent lipid was determined by HPLC analysis using on-
line fluorescence detection (Kasurinen and Somerharju, 1992). For quantification, an inter-
nal standard was added to the cell pellet before the extraction. To determine vesicle binding
to cells, [3H]-cholesterol oleate (50,000 cpm/dish) was included in the donor vesicles.
7.5. Fluorescence imaging
Imaging was carried out on a Zeiss Axiovert 10 microscope equipped with a Pho-
tometrics 200 CCD camera with a thermoelectrically cooled Kodak KAF 1440 chip. A 345
nm (BP 11 nm) excitation filter, a 480 nm (BP 80 nm) emission filter and a 395 nm di-
chroic mirror were used for PyrPL imaging. With the BODIPY lipids 480 nm (BP 30 nm)
and 535 nm (BP 40 nm) excitation and emission filters were used, respectively.
Oxygen was depleted from the medium by adding glucose (0.6 %), glucose-oxidase
(10 U) and catalase (6 U) (Englander et al., 1987). Catalase is present to consume the hy-
drogen peroxide produced upon oxidation of glucose. The proper concentration of glucose
oxidase was determined by measuring the rate of oxygen depletion with an oxygen elec-
trode.
To selectively quench the PyrPL fluorescence in the plasma membrane, 1 ml of
TNP-LPE solution in PBS (30 mM) was added to the chamber containing 1 ml of CO2-
independent MEM.
7.6. Fluorescence and IR spectrometry.
Steady state fluorescence measurements were carried out with a PTI QuantaMaster
spectrofluorometer equipped with a thermostated cuvette holder. The temperature was set
to 25 C unless otherwise indicated. Time resolved measurements were performed on an
ISS GREG 200 (ISS, Champaign, IL) fluorometer, equipped with digital multi-frequency
cross-correlation phase and modulation acquisition electronics. The infrared spectra were
recorded with a Magna-IR 560 Fourier Transform Infrared Spectrometer (Nicolet Inc.,
Madison, WI) as described in (Cheng et al., 1994).
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7.7. Other methods
Lactate dehydrogenase was determined essentially as described in (Absolom, 1986).
Concentrations of unlabeled phospholipids were determined by a phosphate assay (Rouser
et al., 1970) and protein concentrations by a fluorescamine assay (Storrie and Madden,
1990). The donor vesicles for cell labeling were prepared as described in I. Shortly, the ap-
propriate lipids were mixed in chloroform / methanol, dried under a nitrogen stream, kept in
vacuum for one hour to remove any residual solvent, dispersed in buffer and probe soni-
cated.
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8. RESULTS
8.1. Interbilayer transfer of pyrene phospholipids by cyclodextrins
8.1.1. Transfer of pyrene phospholipids between vesicles
To test the ability of CD-derivatives to enhance intermembrane phospholipid trans-
port, we employed a previously developed fluorescence dequenching assay (Fig. 3).
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Fig 3. The assay for transfer of pyrenyl phospholipids between vesicles. In this as-
say, the donor vesicles contain the pyrene lipid under study, TNP-PE as a quencher of py-
rene fluorescence, and unlabeled phospholipids, while the acceptor vesicles consist of un-
labeled lipids only (Somerharju et al., 1987). Transfer of the pyrene lipid molecules from
the donor to the acceptor vesicles result in dequenching of pyrene fluorescence which is
recorded. There is an excess of acceptor vesicles. Q beside a pyrene denotes a quenched,
nonfluorescent pyrene, F a fluorescent pyrene.
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Both mono- and dipyrene species were used (Fig. 1) for the transfer studies. When
16:0-Pyr10PC donors are incubated with the acceptor vesicles only, a very slow increase of
pyrene fluorescence is observed, indicating that the spontaneous transfer of this particular
pyrene lipid is a very slow process. Upon addition of 30 mM CE--CD, a remarkable (
350-fold) increase in the rate of fluorescence enhancement was observed (I, Fig. 1.), indi-
cating that CE--CD greatly accelerates intervesicle translocation of 16:0-Pyr10PC. We
found that the rate of transport is closely proportional to CD concentration.
8.1.2. Comparison of different cyclodextrins
Parallel experiments were carried out with a variety of other cyclodextrin deriva-
tives, but none of them proved to be as efficient as CE--CD. On later experiments we
found that the rate of transfer with CE--CD is quite dependent of pH and at pH 7.4 the
transfer efficiency of unmodified -CD is close to that of CE--CD (see Fig. 4). Because
CE--CD also remarkably enhanced intervesicle transfer of other pyrenyl phospholipids as
well as those labeled with the NBD12- or BODIPY12- fatty acids, CE--CD was initially
chosen for further experiments.
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Fig. 4. Relative efficiencies of PyrPC transfer between vesicles for different cy-
clodextrin derivatives at pH 7.4. All the studied -CD derivatives have similar, lipid hy-
drophobicity -dependent, difference in transfer efficiency for 16:0-pyr10 (black) and di-
pyr10PC (white). Unlike the -CDs hydroxypropyl--CD has very different transfer effi-
ciency for the two lipids. Apparently the -CD cavity is not large enough for two pyrenes,
but one pyrene and an acyl chain fit well in the cavity. This was not explored further be-
cause -CD complicates cell labeling by depleting cellular cholesterol. Legend keys:
CPgCD, carboxypropyl--CD, CEgCD carboxyethyl--CD, SukkCD, succinylated -CD,
CMgCD carboxymethyl--CD, HPgCD hydroxypropyl--CD, gCD, -CD, HPbCD, hy-
droxypropyl--CD, sp, spontaneous transfer.
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8.1.3. Effect of pyrene phospholipid acyl chain length
To obtain information on the mechanism of cyclodextrin-mediated phospholipid
transfer, the effect of the length of the pyrene labeled acyl chain (4 to 14 carbons) on the
rate of CE--CD mediated transfer was investigated (I, Fig. 2.). The rate decreases strongly
(exponentially) with increasing length of the pyrene labeled chain. Analogous results were
obtained for lipids that contained two pyrene labeled chains of identical length (n = 4 – 14)
and with other -CDs. Such a strong chain length -dependency on the rate of fluorescence
increase (probe dilution) clearly indicates that CE--CD enhances monomeric transport of
the labeled lipid molecules, rather than causes fusion or hemifusion between the donor and
acceptor vesicles. Would either of the latter mechanisms dominate, the rate of fluorescence
increase should be independent on the chain length of the pyrene phospholipid, which
clearly is not the case. In addition, the fact that hardly any increase in fluorescence was ob-
served for the pyrene PC with the longest chain (14 carbons) excludes the possibility that
transfer of the quencher molecules, if occurring, would significantly contribute to the ob-
served enhancement of pyrene fluorescence in this assay.
8.1.4. Effect of lipid head group and backbone structure
The effect of the head group on the rate of cyclodextrin-enhanced transfer of py-
rene-labeled phospholipids was next studied (I, Fig. 3). Among glycerophospholipids,
transfer of PG, PE, PS and PC is similarly enhanced while that of PI is enhanced about
twice as much by 5 mM CE--CD. This more rapid transfer of PI is probably due to the
considerable polarity of the head group. Supporting this, transfer of diglyceride, which has
a very small polar moiety, is much less efficient than that of the phospholipids. Pyr10SM is
transported almost 3 times more rapidly than Pyr10PC. The additional hydroxyl group and
double bond in the sphingosine moiety obviously make SM somewhat less hydrophobic
than PC with similar acyl chains. We conclude that the overall molecular hydrophobicity,
rather than some structural details, determines the rate of CE--CD-mediated transport of
the pyrenyl lipids.
8.2. Binding of pyrene lipids by -cyclodextrins
To study whether -CD enhances PyrPL transport by forming soluble complexes in
the aqueous phase or by some other mechanism, binding studies were carried out. Unmodi-
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fied -CD was used instead of the carboxyethyl derivative so that interpretation of the data
would not be complicated by the charged carboxyethyl-moieties. The affinity of pyrene
lipids to -CD is very similar to that of the carboxyethyl analogue at neutral pH (c.f Fig. 4).
Binding of pyrene PC species to -CD was studied by titrating quenched vesicles contain-
ing a dipyrenylacyl (DiPyrnPC) or a monopyrenylacyl PC (16:0-PyrnPC) with -CD in
buffer, followed by reading the fluorescence intensity (Fig. 5; II, Fig. 1).
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Fig. 5.  To study the binding
of pyrene PC species to -CD,
quenched vesicles containing a dipy-
renylacyl (DiPyrnPC) or a monopy-
renylacyl PC (16:0-PyrnPC) were
mixed with varying concentrations of
-CD in buffer and the fluorescence
intensity was recorded after the
equilibrium had been reached. There
is an increase in pyrene fluorescence
intensity due to removal of the PyrPC
molecules from the lipid bilayer
containing the quencher molecules
(trinitrophenyl-PE). Q beside a py-
rene denotes a quenched, nonfluo-
rescent pyrene, F a fluorescent py-
rene.
Equation 1 was then fitted to the fluorescence titration data. For DiPyr4-, DiPyr6-
and DiPyr8PC the best fits were obtained when assuming the stoichiometry of two -CD
molecules for each PC, while for DiPyr10-, DiPyr12- and DiPyr14PC best fits were obtained
when assuming a 3:1 stoichiometry. Parallel studies with 16:0-PyrnPCs showed that the
binding stoichiometry was 2:1 when n was 4, 6, 8 or 10 but changed to 3:1 for n = 12 or 14
(II, Fig. 1).
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8.2.1. Thermodynamics of the complex formation
The thermodynamic parameters G, H and S for complex formation were deter-
mined from the temperature-dependence of the association constant K for 10:0-Pyr10PC/-
CD complex (II, Fig. 3). The following values were obtained: G = 0.34 kJ/mol; H =
0.475 kJ /mol; T298 * S = 0.13 kJ/mol (S = 0.43 kJ/mol*K). These numbers indicate that
transfer of 10:0-Pyr10PC form the bilayer to the -CD cavity is a nearly energy-neutral pro-
cess. This is not an unexpected result, since the acyl chains of a PyrPC are transferred from
one hydrophobic environment (i.e., the bilayer interior) to another one (i.e., the -CD cav-
ity) and the head group is located in the aqueous phase in both cases.
An activation energy of +92 kJ/mol was determined from the temperature-
dependence of DiPyr10PC binding to -CD. This high value indicates that the efflux of the
PC molecule from the bilayer is the rate-limiting step of the binding process.
8.2.2. Spectroscopic characterization of pyrene PC/-cyclodextrin complex
The structure of the PyrPC/-CD complex was studied with several physical meth-
ods: absorbance, steady state and time-resolved fluorescence, and FTIR spectrometries. The
absorption as well as the excimer excitation spectra obtained for DiPyrnPC/-CD complexes
are strongly broadened. This is a clear sign of ground state dimer formation (Winnik, 1993).
Steady state emission spectra show that complex formation greatly increases the probability
of excimer formation of DiPyr4PC and DiPyr10PC, as compared to bilayer associated lipids.
This indicates that the pyrenes are constrained to lie close to each other in the complex.
Time-resolved studies, showing a greatly enhanced excimer formation rate, strongly sup-
port this view. FTIR-studies indicate marked suppression of certain deformation modes of
the pyrene ring in the DiPyr4PC– -CD complex. This is compatible with the idea that py-
renes are forced to lie close together in the complex; the pyrene ring is quite rigid and thus
close apposition of two pyrenes is expected to limit ring deformations. Neither broadening
of the excitation peaks nor excimer formation was observed for mono-PyrPCs. Collectively
these data indicate that the pyrene moiety of a pyrene lipid is inside the cyclodextrin cavity,
the pyrene moieties of a dipyrene lipid are located very close to each other in the cavity and
that both chains of a monopyrene lipid are in the same cavity (see II).
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8.3. -cyclodextrin-mediated transfer of fluorescent lipids from vesi-
cles to cultured cells
8.3.1. Transfer assays
We next studied whether CE--CD catalyzes transport of fluorescent phospholipids
from vesicles to cells in culture. Vesicles containing a pyrene- or BODIPY-labeled phos-
pholipid were incubated with cell monolayers at RT or 37 C and the amount of cell-
associated fluorescent lipid was determined using either fluorescence imaging or spectros-
copy. Donor vesicles labeled additionally with [3H]-cholesterol ester were used to assess
the amount of donor vesicles adhering to or fusing with the cells (for details see Experi-
mental procedures). For the imaging studies dipyrenyl phospholipids were used because
excimer fluorescence is more readily visualized with the imaging system used than the
monomer fluorescence. Furthermore, the wide separation of the excitation (345 nm) and
emission peaks (480 nm) avoids excitation/emission crossover as well as allows efficient
correction for background fluorescence (see below). Another important advantage of the
dipyrenyl derivatives is that the presence of fatty acid and/or lysolipid impurities in the do-
nor vesicles does not interfere with the interpretation of images, as these compounds do not
display detectable excimer fluorescence in cells. Such selective imaging of the intact phos-
pholipid is of course impossible with the monopyrenyl- or BODIPY-derivatives.
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8.3.2. Mechanism of cell labeling
Fig. 6. -CD greatly enhances transfer of DiPyr10PC from donor vesicles to cells.
Monolayers of human fibroblasts on coverslips were incubated with DiPyr10PC containing
donor vesicles for 30 min at 25 °C, washed and imaged as detailed under "Experimental
Procedures." In panel a 30 mM CE--CD was present during the incubation while in panel
b there was no CD present. The camera settings and image adjustments are identical in
both images. The inset in panel b shows the original image with the pixel intensities multi-
plied by a factor of 20.
Fig. 6 shows human fibroblast (HF) cells incubated with donor vesicles containing
DiPyr10PC in the presence or absence of 30 mM CE--CD. Clearly visible excimer fluores-
cence, mainly on the plasma membrane, is observed in the presence of -CD (panel a),
while practically none is detectable in its absence (panel b). -CD also strongly enhanced
transfer of the BODIPY-derivatives from the donor vesicles to cells. However, significant
labeling of cells by BODIPY-SM occurred also in the absence of cyclodextrin, probably
because of the relatively low hydrophobicity of the BODIPY-derivatives.
Analogous labeling experiments with other DiPyrnPC species were carried out in
order to establish the limits of the method, as well as to confirm that the enhanced labeling
in the presence of cyclodextrin is due to monomeric transfer of the fluorescent lipid rather
than fusion or adherence/endocytosis of the donor vesicles (I, Fig. 5). As expected, most
efficient -CD-mediated labeling was obtained with DiPyr4PC. The efficiency decreased
systematically with increasing length of the acyl chains and with DiPyr14PC virtually no
labeling was observed. For DiPyr6PC significant and for DiPyr8PC some labeling was ob-
served also in the absence of -CD, but not for the long-chain derivatives. The fact that
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practically no labeling with the most hydrophobic pyrene lipids was observed in the ab-
sence of -CD provides strong evidence that -CD enhances monomeric transfer of the py-
rene derivatives rather than induces vesicle-cell fusion, adherence or endocytotic uptake of
vesicles. These data also show that DiPyr10PC is the most hydrophobic dipyrenyl derivative
for which reasonable levels of labeling were achieved under the present labeling conditions.
To confirm that -CD indeed mediates monomeric transfer of the fluorescent lipids
rather than causes fusion or association of the donor vesicles with the cells, BHK cell
monolayers were incubated with donor vesicles containing BODIPY-SM and [3H]-
cholesterol oleate, a non-transferable liposomal marker, in the presence of 0 - 30 mM CE--
CD for 30 min at RT (I, Fig 6). The amount of cell-associated BODIPY-SM increased
strongly with the CE--CD concentration up to 15 mM CE--CD. At this concentration,
about 5 % of the liposomal BODIPY-SM become cell-associated. In contrast, only about
0.3 % of the [3H]-cholesterol ester, the liposomal marker, was associated with the cells in-
dependently of the CE--CD concentration used. Parallel results were obtained for Di-
Pyr6PC except that somewhat less fluorescent PC was transferred to the cells (I, Fig. 6).
These data are consistent with the proposition that -CD enhances monomeric transport of
the fluorescent phospholipids from donor vesicles to cells.
To study the initial site of introduction of fluorescent lipids to cells we compared
cell labeling with pyrene PC to labeling with pyrene PS. In BHK cells labeled with Di-
Pyr8PC and then chased for 5 hours at 37 C, the plasma membrane fluorescence was
strongly reduced as compared to situation before the chase, while there is a marked increase
in the labeling of intracellular structures, including punctate pericellular and more diffuse
perinuclear structures (I, Fig. 7a). These may represent secondary endosomes and the endo-
sytic recycling compartment, respectively (Mukherjee et al., 1999). On the other hand, no
significant labeling of the mitochondria or the nuclear membrane was apparent. These
findings indicate that dipyrene PCs are initially introduced as monomers to the outer leaflet
of the plasma membrane and are later incorporated to endosomes and related organelles. If
fusion of the vesicles with cell membrane would have occurred, labeling of the mitochon-
dria and the nuclear membrane would be expected (see below and cf. Pagano and Sleight,
1985).
When BHK cells were analogously labeled with DiPyr8PS for 15 min at 37 C and
then chased for 5 hours at 37 C, we saw prominent labeling of mitochondria (I, Fig. 7b).
Labeling of this organelle is in agreement with previous data obtained for NBD6PS (Martin
and Pagano, 1987), NBD12PS (Kobayashi and Arakawa, 1991) and DiPyr4PS (Kasurinen
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and Somerharju, 1995). Apparently the PS molecules are initially introduced to the outer
leaflet of the plasma membrane from where they move rapidly to the inner leaflet with the
assistance of the aminophospholipid translocase (Devaux, 1992). From the inner leaflet the
fluorescent PS molecules move further, possibly via spontaneous diffusion (see below), to
various organelles, including mitochondria, where they are decarboxylated to PE
(Kobayashi and Arakawa, 1991; Jasinska et al., 1993). In conclusion, the intracellular dis-
tribution modes of DiPyr8PC and -PS are compatible with the proposition that -CD medi-
ates monomeric incorporation of the fluorescent lipids initially to the outer leaflet of the
plasma membrane, rather than induces fusion or endocytosis of the donor vesicles.
8.3.3. Effect of -cyclodextrin on cell viability
Incubation with -CD does not compromise plasma membrane intactness as meas-
ured by lactate dehydrogenase and Trypan Blue leakage or long term cell viability meas-
ured as protein mass per dish (data not shown). Unlike -CD (Kilsdonk et al., 1995), -CD
incubation does not seem to affect cellular cholesterol content. To study whether incubation
with -CD and donor vesicles alters the phospholipid composition of the cells, mass spec-
troscopic measurements (Han and Gross, 1994; Brügger et al., 1997) of the medium and the
cells were carried out. Our analyses of cellular lipid composition indicated that -CD does
not extract cellular phospholipids like -CD does (Ohtani et al., 1989). Unfortunately, the
phospholipid composition of the labeling medium could not be determined because of
compounds present interfering with the mass-spectroscopic analysis. The analysis of the
total cellular lipid composition does not fully exclude the possibility that some changes in
the lipid composition of the plasma membrane outer leaflet might occur, since this com-
partment contains only a fairly small fraction of the total cellular phospholipid.
8.4. Fluorescence imaging of pyrene lipids in cells
8.4.1. Prevention of photobleaching
Photobleaching is a major problem in quantitative fluorescence imaging. Oxygen
often plays a central role in this process (Tsien and Waggoner, 1995). The lifetime of ex-
cited pyrene is in the order of 100 ns (Morrison, 1988) and therefore oxygen bleaches py-
rene fluorescence very effectively at normal atmospheric pressure (Xu et al., 1995). This
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led us to test whether deoxygenation of the medium would counteract photobleaching of
pyrene lipids in cells. The enzymatic deoxygenation protocol described by Englander et al.
(1987) was used.
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Figure 7. Kinetics of pyrene
photobleaching in cells. Fibroblasts
were labeled with pyrenedodecanoate for
one hour as described in (Kasurinen et
al., 1990) and then subjected to imaging
with continuous excitation through a 345
nm (11 nm BP) filter either in the pres-
ence (closed symbols) or absence (open
symbols) of the oxygen-depleting rea-
gents. The upper panel shows bleaching
of the pyrene label in membranes. The
half times of bleaching in the presence or
absence of deoxygenation were deter-
mined to be 9400 and 71 s, respectively.
The lower panel shows the bleaching of
pyrene fluorescence in brightly-labeled
neutral lipid droplets. The half-times of
bleaching with or without deoxygenation
were 5400 and 8.5 s, respectively. In the
absence of deoxygenation also another
(minor) bleaching component with half-
time of 72 s was observed. This compo-
nent may relate to photobleaching of py-
rene phospholipids in membranes below
and above the lipid droplets in focus.
.
Deoxygenation has a very strong effect on the photobleaching of lipid-bound pyrene
fatty acid in BHK cells. In the absence of the oxygen depleting system, the rate of photo-
bleaching was rapid, i.e. the pyrene fluorescence virtually disappeared after 5 min of con-
tinuous excitation. Instead, when oxygen had been depleted, photobleaching was negligible.
Quantitative image analysis (Fig. 7) showed that deoxygenation diminished pyrene photo-
bleaching about 130-fold (III). The effect of deoxygenation was even more dramatic for the
cytoplasmic neutral lipid droplets where the rate of photobleaching decreased approxi-
mately 1000-fold.
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8.4.2. Effect of oxygen on cell viability
Depletion of oxygen could potentially damage the cells by preventing aerobic me-
tabolism and thereby reducing cellular energy levels. However a 30 minute deoxygenation
did not affect the cellular energy status (III, Fig. 3) or protein synthesis. Furthermore, de-
oxygenation was not observed to cause any visually detectable damage to the cells during
the first 20 min. Later, however, plasma membrane blebbing was observed, possibly due to
depletion of cellular energy levels (Scott, 1976; Johnson et al., 1994).
8.4.3. Elimination of background fluorescence
Pyrene has a sharp excitation maximum close to 345 nm but is hardly excited at 360
nm, while the cellular autofluorescence/scattering shows little wavelength-dependency in
this region. Thus, it should be possible to largely eliminate the cellular background fluores-
cence/scatter by subtracting an image obtained with an 360-nm excitation filter from one
recorded with an 345-nm filter. To test this, images of unlabeled cells were obtained with
345 and 360 nm excitation and the latter image was subtracted from the former, which had
been multiplied by an empirically determined factor to correct for wavelength-dependency
of the optical transmission and lamp output. An essentially “black” image resulted indicat-
ing that the method properly corrects for the background (III, Fig 4). We tested the useful-
ness of this protocol further by labeling BHK and mucolipidosis IV cells with a low con-
centration of DiPyr4PC (III, Fig 5). When BHK-cells were imaged with a 345-nm pyrene
filter most of the fluorescence was at the plasma membrane. When a 360-nm filter was used
most of the fluorescence was internal, as expected for cellular autofluorescence. When the
360 nm image was subtracted from the 345 nm image, the overall image contrast improved
remarkably. However, besides this contrast enhancement, which is largely due to elimina-
tion of the cell-independent signal, the effect of background subtraction was not obvious
from these images. This is largely due to the fact that the autofluorescence of BHK cells
with 345-nm excitation is quite low. For the mucolipidosis-IV cells, which typically have
rather intense autofluorescence (Goldin et al., 1995; Chen et al., 1998), the subtraction of
the 360-nm image from the 345-nm image also provided a reasonable background correc-
tion.
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8.4.4. Selective imaging of pyrene lipids in the plasma membrane.
A previous study indicated that N-trinitrophenyl-lysophosphatidylethanolamine
(TNP-LPE), when added to the medium, selectively quenches the pyrene lipids located in
the plasma membrane of fibroblasts (Kasurinen and Somerharju, 1995). This finding sug-
gested that one could obtain plasma membrane images free from contribution by internal
membranes by taking an image before and after the addition of the quencher followed by
subtraction of the latter from the former. To study this issue, BHK cells were incubated
with donor vesicles containing DiPyr4PC and then chased for 2 h at 37 C. This protocol
guarantees that the probe is present in both the plasma membrane and various intracellular
structures, mainly endosomes and lysosomes (Kasurinen and Somerharju, 1995). The cells
were imaged, TNP-LPE was then added to the medium and the cells were imaged again.
The plasma membrane fluorescence virtually disappeared, but the intracellular fluorescence
appeared to remain unaffected (III, Fig. 6). These findings indicate that TNP-LPE indeed
selectively quenches DiPyr4PC in the plasma membrane. Supporting this conclusion, only
the plasma membrane was visible in the difference image. The quencher seems to penetrate
the plasma membrane only very slowly, since no apparent changes in the internal fluores-
cence were observed during several minutes of follow-up. An image that predominantly
represents the outer leaflet of the plasma membrane is acquired, since DiPyr4PC is largely
restricted to this leaflet (Kasurinen and Somerharju, 1995). Control experiments (III, Figs.
7-8) indicated that TNP-LPE also quenches the pyrene lipids in the inner leaflet, even if it
itself is probably restricted to the outer leaflet. If TNP-LPE had access to the inner leaflet of
the plasma membrane it would rapidly partition to all the cytosolic membranes due to its
high hydrophilicity as a lysolipid. If this happens, also fluorescence inside the cell would be
quenched which it not the case. Accordingly, one can also obtain specific images of the in-
ner leaflet, by labeling the cells with a pyrene lipid that is present in the inner leaflet only,
such as PS (III, Fig. 7).
8.4.5. Pyrene fluorescence quenching in model membranes
Quenching of pyrene lipid fluorescence by TNP-LPE was also studied in unilamel-
lar vesicles. The vesicles consisted of POPC, POPA, cholesterol and either 16:0/Pyr8PC,
16:0/Pyr10PC or 16:0/Pyr12PC. The pyrene lipid was present either in both leaflets of the
vesicles (symmetric vesicles) or in the outer leaflet only (asymmetric vesicles). When the
symmetric vesicles were titrated with TNP-LPE the length of the pyrene-labeled chain had
little effect on the quenching efficiency (III, Fig. 8). In these vesicles the pyrenes in the in-
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ner leaflet come closer to the quencher in the outer leaflet as the acyl chain length of the
PyrPC increases. This seems to negate the effect of the pyrenes moving farther from the
quencher in the outer leaflet with increasing chain lenght. In the asymmetric vesicles the
quenching efficiency diminished with increasing length of the pyrene-labeled acyl chain as
all the pyrenes in the vesicle move farther from the quencher (III, Fig. 8). We used previ-
ously derived equations to determine the effective R0 value for this energy transfer -
dependent quenching (Wolf et al., 1992). Fitting these equations to the data gave R0 the
value of 15 Å for both the symmetric and asymmetric vesicles. This value of R0 is valid for
a single donor-acceptor pair, but in the membrane there are, except for very low acceptor
(quencher) concentrations, several acceptor molecules at a distance from the donor which
allows energy transfer to take place. It was calculated that at moderate quencher concentra-
tions the effective R0 is close to 20 Å, i.e., 50 % of pyrenes at this distance are quenched.
Since the chromophore of TNP-LPE is probably located at or has access to the bi-
layer/water interface (van Duijn et al., 1985), and since the centroid of a pyrene attached to
an acyl chain of 12 carbons is about 14.5 Å from the interface (Sassaroli et al., 1995), it is
clear that any pyrene phospholipid present in the same leaflet as the quencher should be ef-
ficiently quenched. Also the pyrenes in the opposite leaflet should be quite efficiently
quenched, at least when attached to an acyl chain of moderate length. For example, the
centroid of a pyrene attached to a 10 carbon chain is about 13.5 Å from the bilayer/water
interface (Sassaroli et al., 1995). Since the thickness of the hydrocarbon region of a
PC/cholesterol bilayer is approximately 30 Å (Nezil and Bloom, 1992) the pyrenes would
be only 16 - 17 Å away from the TNP-groups in the opposite leaflet. Since the distance de-
pendency of quenching efficiency is a 6th power equation, it is feasible that TNP-LPE in the
outer leaflet of the plasma membrane can efficiently quench the fluorescence of DiPyr10 -
lipids in the inner leaflet as the distance between the pyrene and the quencher is under the
R0. When multilamellar liposomes containing 16:0/Pyr10PC were titrated with TNP-LPE,
the quenching was much less efficient than with unilamellar vesicles. This indicates, in ac-
cordance with the cell experiments, that TNP-LPE does not readily penetrate thorough the
membrane.
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8.5. Hydrophobicity-dependent transfer of dipyrenyl PS from
plasma membrane to mitochondria.
Previous studies have shown that fluorescent PS species are rapidly transported
from plasma membrane to mitochondria (Kobayashi and Arakawa, 1991; Kasurinen and
Somerharju, 1995). To study whether this rapid transport is an artifact due to the low hy-
drophobicity of the PS species used, we compared intracellular distribution of short- and
long-chain DiPyrnPS species. After DiPyr6PS or DiPyr8PS labeling the plasma membrane is
the most prominently labeled structure. After three to five hours’ chase the mitochondria
were typically the most strongly labeled structure (I, Fig 7). After DiPyr10PS labeling most
of the label is also in the plasma membrane (I, Fig. 8). After 3 hours chase, the juxtanuclear
region, possibly the endosomal recycling compartment (cf. Mukherjee et al., 1999) is
prominently labeled, along with the plasma membrane. At 5 hours, the probe distribution
remained similar except that juxtanuclear labeling was somewhat diminished and punctate
fluorescence was observed. After 23 hours of chase, the overall fluorescence intensity was
somewhat diminished and, in most cells, the punctate structures were more prominent than
before. In none of these images DiPyr10PS was seen to be present in mitochondria. This is
in striking contrast with what we observed here for DiPyr6-8PS and what has been previ-
ously observed for DiPyr4PS and NBD12PS (Kasurinen and Somerharju, 1995; Kobayashi
and Arakawa, 1991). It is concluded that short-chain (hydrophilic) PS species do not prop-
erly mimic trafficking of natural, typically long-chain PS species.
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9. DISCUSSION
9.1. Transfer of pyrene phospholipids by cyclodextrins
9.1.1. Mechanism of -CD -mediated phospholipid transfer
The most probable model for -CD -mediated PyrPL transfer is that the lipid mole-
cule first fully detaches from the bilayer and then associates with 2-3 -CD molecules in the
aqueous phase. Subsequently the lipid partitions from the complex to any available mem-
brane. Two findings strongly support this view: First, the activation energy of the formation
of a DiPyr10PC/-CD complex (+92 kJ/mol) is very high and similar to that obtained pre-
viously for the efflux of a pyrene-labeled and other phospholipid molecules from a phos-
pholipid surface to the aqueous phase (Massey et al., 1982b; McLean and Phillips, 1984;
Wimley and Thompson, 1990; Pownall et al., 1982). Secondly, the rate of complex forma-
tion decreases exponentially with increasing acyl chain length of PyrPC. Analogous be-
havior has been observed for spontaneous interparticle transfer of PyrPCs (Massey et al.,
1982b) and unlabeled PCs (Ferrell et al., 1985), where the efflux from the donor surface to
the aqueous phase was considered to be the rate-limiting step. So the rate of lipid efflux to
the aqueous phase, which is determined by its hydrophobicity (Massey et al., 1982b;
McLean and Phillips, 1984; Massey et al., 1985; Wimley and Thompson, 1990; Reinl and
Bayerl, 1994) most propably sets the ultimate limit for CD-mediated interbilayer lipid
transfer. This has already been shown with sterols: at constant surface pressure the desorp-
tion rate of different sterols from a lipid monolayer to -CD is largely determined by their
hydrophobicity (Ohvo and Slotte, 1996).
The thermodynamic data obtained for the transfer of 10:0-Pyr10PC from a bilayer to
the -CD complex indicate that this process is nearly energy-neutral. The very small value
of G derives from the PyrPC molecule being transferred from one amphipathic environ-
ment to another, i.e., from a lipid bilayer to the CD cavity. Both the acyl chains and the
head group experience a relatively insignificant change in their environment.
The entropy of the system is a complicated issue because there are many factors in-
volved. The rotational entropy of the PyrPC molecule may increase upon complex forma-
tion because the PyrPC can tumble isotropically with the complex, while this is not possible
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in the anisotropic bilayer environment. The removal of a PyrPC molecule from the bilayer
is likely to increase the entropy of the latter due to increased conformational freedom of the
matrix lipid acyl chains that were proximal to the relatively bulky and rigid pyrene moiety.
The cavity on the CD-molecule contains water molecules that have a lower entropy than the
bulk water molecules (Tabushi et al., 1978). The release of these water molecules upon
formation of the PyrPC/-CD complex is an entropically favorable process. The entropy of
the -CD molecules participating in the complexes should decrease due to their diminished
rotational freedom as compared to uncomplexed molecules. Apparently, all these factors
together cause the total entropy of the system to be nearly constant. Also H of PyrPC
transfer from the bilayer to the -CD complex is very low. This is most probably a result of
many compensating factors (see III) one of which is again the water molecules residing in-
side the uncomplexed cyclodextrin molecules
9.1.2.  Characteristics of the pyrene PC/-cyclodextrin-complex
DiPyrnPCs with short acyl chains form a 1:2 complex with -CD, while those with
longer chains seem to form a 1:3 complex. The shift from a 1:2 to a 1:3 complex occurs
when the length of the pyrene labeled chains is  10 carbons. With 16:0-PyrnPC species the
shift from a 1:2 to 1:3 complex occurs when the length of the labeled chain (n) is  12 car-
bons. This may be because the overall cross-sectional area of monoPyrPCs (in its all-trans
conformation) is smaller than that of the -CD cavity (as demonstrated by experimenting
with space-filling models, see below), the acyl chains kink to maximize the van der Waals
interactions with the -CD molecules. Such kinking would make the effective acyl chain
length shorter than what is the case with DiPyrnPCs. Tests with space-filling models indi-
cate that the labeled chains of a DiPyrnPC are almost fully included inside the combined
cavity of 2 -CD molecules when n 	 10 (when placing the carbonyl carbons just outside
the cavity), but a cavity consisting of 3 -CD molecules is needed to shield longer pyrenyl
chain from the aqueous medium. In conclusion, the spectroscopy results indicated that the
two acyl chains of a pyrene lipid molecule share the same -CD cavity, consisting of 2-3 -
CD molecules.
9.1.3. Cyclodextrins as carriers for other lipids.
Knowledge on factors that determine the rate of cyclodextrin-mediated PyrPL trans-
fer should help to develop more efficient transfer methods also for other lipids. While -CD
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and its derivatives seem to enhance the transport of pyrene-labeled phospholipids more ef-
ficiently that - or -cyclodextrins, the latter may actually be more efficient carriers of
natural phospholipids. This is because the cross-sectional area of the acyl chains of the
natural lipids more closely corresponds to the dimensions of the cavity of - or -CD. Ex-
periments with space-filling models indicate that the cavity of -CD can accommodate two
normal acyl chains while that of -CD only one. Previous studies have indicated that -CD
interacts more strongly with unlabeled phospholipids than the - or -derivatives (Irie et al.,
1982; Nishijo et al., 2000; Fauvelle et al., 1997; Debouzy et al., 1998). According to the
present study hydrophobicity-dependent efflux from the bilayer is the rate-limiting step in
CD-mediated lipid transfer. However, this may not be applicable to all lipids and cyclodex-
trins because the activation energy for cholesterol transfer from a model membrane to -CD
is only 8.4 kJ/mol while to apo-HDL-phospholipid acceptor particles it is 84 kJ/mol. In this
case cholesterol molecules desorbing from a membrane surface can possibly diffuse di-
rectly into the hydrophobic core of a cyclodextrin molecule without having to desorb com-
pletely into the aqueous phase before being sequestered by the acceptor (Yancey et al.,
1996). On the other hand, it has been shown that sterol desorption from a monolayer is de-
pendent on sterol hydrophobicity and that -CD does not penetrate into the membrane
(Ohvo and Slotte, 1996). The low value for activation energy of cholesterol transfer to -
CD is most probably due to the fact that this particular CD species represents a very spe-
cific, non-physiological, type of cholesterol acceptor.
Typical natural phospho- and glycolipid species (c.f. table 1 in I) have quite high
hydrophobicity and accordingly low off-rate from a membrane. It is thus unlikely that even
the optimal CD-derivatives could mediate efficient transfer of these lipids, unless donors
providing very high off-rates can be developed. Previous studies have shown that the rate of
lipid efflux is strongly dependent on properties of the donor membrane. Factors increasing
the off-rates include high surface curvature (Massey et al., 1984; Lund-Katz et al., 1982)
and lipid composition that leads to looser lateral packing of the membrane (Massey et al.,
1982a). Also bilayer perturbing molecules, like bile salts (Nichols, 1986), hydrophobic
peptides or solvents could be of use.
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9.2. -cyclodextrin-mediated labeling of cells with hydrophobic fluo-
rescent phospholipids.
-CD greatly accelerates translocation of hydrophobic pyrene-labeled phospholipids
from vesicles to cells. The transfer of BODIPY12- and NBD12-phospholipids was also re-
markably enhanced by -CD, thus demonstrating that this is not a phenomenon spesific for
the pyrene derivatives. Several lines of evidence indicate that -CD enhances intermem-
brane phospholipid transfer by increasing the effective concentration of the fluorescent
phospholipid in the aqueous phase, rather than by inducing membrane fusion or hemifu-
sion.
Several lines of evidence indicate that incubation with the donor vesicles and -CD
is not harmful to the cells. Cell growth was not detectably affected by the labeling proce-
dure. Plasma membrane remained intact as the incubation did not induce leakage of lactate
dehydrogenase, a cytoplasmic enzyme, to the medium. Further, -CD did not extract cho-
lesterol from cells like -CD does and cellular cholesterol levels remained constant
throughout the labeling. Extraction of phospholipids from cells was not observed. It has
been shown previously that incubation of red blood cells with -cyclodextrin results in sig-
nificant extraction of cellular phospholipids, while - and -cyclodextrins were much less
efficient in this respect (Ohtani et al., 1989). The larger hydrophobic cavity of -
cyclodextrins apparently favors complex formation with fluorescent lipids having bulky
groups in the acyl chain(s), but disfavors complexation of both phospholipids with natural
acyl chains and cholesterol.
Short-chain, hydrophilic lipids can be efficiently extracted from exposed compart-
ments, like the outer leaflet of the plasma membrane by using phospholipid vesicles or al-
bumin as acceptors  (van Meer et al., 1987). This allows one to assess the amount of the
fluorescent lipid in the outer leaflet of the plasma membrane, which is useful when moni-
toring recycling of lipids, for example. Incubation with -CD (
 acceptor vesicles) does not
remove medium or long chain dipyrenyl phospholipids efficiently from the outer leaflet of
the plasma membrane. Curvature of the plasma membrane is quite low and the outer leaflet
of the membrane is rich in tightly packed saturated sphingolipids and cholesterol (Allan,
1996; van Meer and van Genderen, 1994). Accordingly, lipids leaving the plasma mem-
brane should have quite low off-rates, which helps to explain this. It is notable that selective
quenching techniques can be used to determine the fraction of a pyrene lipid located in the
plasma membrane (see below).
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Currently DiPyr10 –lipids are the most hydrophobic ones that can be introduced to
cell with a high enough efficiency for lipid trafficking studies. Many normal phospholipids
are even more hydrophobic than these, and accordingly, the labeling method should be re-
fined to include DiPyr12-14 –lipids in the usable hydrophobicity range. This may be possible
by modifying the donor particles to give higher off-rates (see above).
9.3. Improved imaging of pyrene labeled lipids in living cells
9.3.1. Prevention of  photobleaching of pyrene lipids in cells
Deoxygenation of the medium virtually eliminates photobleaching of pyrene lipids
in cells (Fig. 7). Deoxygenation was achieved simply by adding glucose oxidase and glu-
cose into the medium. Oxidation of glucose consumes molecular oxygen (Englander et al.,
1987). This method is very simple and rapid as adequate deoxygenation is obtained within
1-2 minutes. Furthermore, the cells do not seem to suffer detectably, at least during the first
20-30 min of deoxygenation, as indicated by the maintenance of ATP levels and by the lack
of inhibition of protein synthesis. This period is more than sufficient for various types of
manipulations and sequential imaging. Similar deoxygenation methods have been tested
previously for other fluorophores (Bloom and Webb, 1984). However, either no beneficial
effect was observed or the effect was far less dramatic than what was observed for pyrene
in this study. The mechanism of oxygen-dependent pyrene photobleaching is not clear, but
reaction of oxygen with the triplet state of the fluorophore is an obvious possibility (Tsien
and Waggoner, 1995).
9.3.2. Correction for autofluorescence and light scattering
In addition to photobleaching, cellular autofluorescence and cell-independent signal
(i.e., fluorescence or scatter from the optics, coverslip or the medium) can severely impede
quantitative imaging (Jericevic et al., 1989). These can be efficiently eliminated from py-
rene excimer images by taking images with 345 and 360 nm excitation followed by sub-
traction of the latter image from the former. This is simplified by the large ( 130 nm)
Stokes shift of the pyrene excimer fluorescence. In principle, a similar background correc-
tion can be done for pyrene monomer images (as well as for those obtained with other fluo-
rophores). Because the pyrene monomer has a much smaller (30-40 nm) Stokes shift this is
technically much more demanding and was not attempted here. Another problem with py-
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rene monomer imaging is that most microscope objectives are not well corrected at less
than 400 nm where the monomer fluorescence is observed. This tends to result in blurred
images.
9.3.3. Selective imaging of the plasma membrane and its leaflets
Fluorescent lipid analogues are potentially useful tools for imaging of the plasma
membrane, but their use is hampered by the fact that it is virtually impossible to restrict the
probes only to the plasma membrane, since a significant fraction is very rapidly incorpo-
rated to endocytotic vesicles (Chen et al., 1997). Because some of these vesicles are very
close to the plasma membrane, they can, due to the limited z-resolution of microscope ob-
jectives (Young, 1989), obscure the plasma membrane images. Although pre-fixation of the
cells could prevent probe internalization, it is likely to lead to other serious artifacts as dis-
cussed above. This study provides evidence that the pyrene lipids in the plasma membrane
can be selectively imaged in the presence of strong intracellular labeling by using a plasma
membrane specific quencher, TNP-LPE, and image subtraction. Experiments with cells and
liposomes indicated that TNP-LPE efficiently quenches the pyrene lipids present in the
same leaflet. Also the pyrenes in the opposite leaflet are effectively quenched, at least when
attached to a longer acyl chain. From the determined R0-value it is obvious that pyrene lip-
ids present in endocytotic vesicles cannot be significantly quenched and should not contrib-
ute to the plasma membrane images. It is possible to selectively image either the outer or
inner leaflet of the plasma membrane by labeling the cells with pyrene phosphatidylcholine
or -serine, respectively. This offers a possibility to probe the physical properties of either
leaflet independently of each other. Selective quenching also allows one to determine the
fraction of cell-associated fluorescent lipid in the plasma membrane, which is very helpful
when studying lipid endocytosis and trafficking. However, it must be kept in mind that
TNP-LPE as an unnatural lysolipid may perturb normal function of the plasma membrane
and so quenching should be done only as an end point for an experiment. It is also possible
that the quencher might interfere with the lateral organization of the plasma membrane,
which might affect the results if one attempts to image rafts or caveolae. It should also be
noted that fixation of cells seems to allow fairly rapid permeation of TNP-LPE through the
plasma membrane, as indicated by quenching of intracellular structures as well. The rea-
sons for this permeability increase are not clear but could result from modification of the
head groups of PE and PS by the aldehyde fixative (see above). Quenching of the plasma
membrane fluorescence can also be used to improve the visibility of intracellular structures.
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9.4. Advantages of hydrophobic lipid analogues in lipid trafficking
studies
As noted above, it is important to use hydrophobic analogues when studying intra-
cellular trafficking of lipids. -CD provides a simple way to introduce hydrophobic fluores-
cent phospholipids to cells in culture, thereby making it feasible to study many unresolved
aspects of intracellular phospholipid trafficking. For example, intracellular trafficking of
plasma membrane PS can now be studied more readily than before. PS comprises as much
as 30 mole% of the phospholipids of the inner leaflet of the plasma membrane (Allan,
1996), and it is unclear how the cell can maintain such a high concentration of PS in the
inner leaflet. One possibility is that PS in the plasma membrane consist predominantly of
saturated, hydrophobic species (Keenan and Morre, 1970), and the hydrophobicity could
prevent their spontaneous diffusion from the plasma membrane to other organelles and
eventually to mitochondria where they would be decarboxylated to PE (Voelker, 1997;
Vance and Shiao, 1996). Hydrophobic PS species might become enriched in the plasma
membrane because of preferential transfer of the less hydrophobic species to mitochondria
after their synthesis in the ER (Heikinheimo and Somerharju, 1998), or due to their prefer-
ential association with membrane domains or "rafts" destined to the plasma membrane (van
Meer, 1998). The present results strongly support this model by showing that the hydro-
phobic fluorescent derivative, DiPyr10PS, labels the plasma membrane and various endo-
cytic compartments but not the Golgi apparatus or mitochondria.
Caveolae and "rafts" are another example of a phenomenon that can be studied more
readily using the present technology. These domains may play a crucial role e.g. in signal
transduction and lipid and protein trafficking. (Simons and Ikonen, 2000; Bretscher and
Munro, 1993; Simons and Ikonen, 1997; Anderson, 1998). The actual lipid compositions as
well as the physical properties of these domains are largely unknown. By using the present
method one could introduce to cells fluorescent analogues of the putative domain lipids,
i.e., SM and glycosphingolipids, and then use fluorescence imaging and/or spectroscopy to
obtain information on the physical properties of the domains. In addition, one could make
use of the fact that cholesterol has a marked effect on the intramolecular excimer formation
by dipyrenyl phospholipids (Sassaroli et al., 1995; Virtanen et al., 1995) to microscopically
map the concentration of cholesterol in different membrane domains.
It has been previously shown that NBD12PS moves rapidly from the plasma mem-
brane to the Golgi apparatus and mitochondria (Kobayashi and Arakawa, 1991). Since the
authors considered this fluorescent species to be “relatively nonexchangeable”, and since
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inhibition of vesicular transport had no effect on labeling of the Golgi apparatus and mito-
chondria, they proposed that the transport of NBD12PS from the plasma membrane to these
organelles is probably mediated by a lipid transfer protein. However, since the NBD12PS is
far less hydrophobic than typical native species (see table 1 in I), it can certainly move from
the PM to mitochondria by spontaneous diffusion via the cytoplasm and no transfer protein
is needed. Results like this underline the importance of using hydrophobic analogues when
studying intracellular trafficking of lipids that have access to the cytoplasmic leaflet of or-
ganelle membranes.
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10. CONCLUSIONS
1. -CD forms complexes with several fluorescent phospholipid analogues and
transfers these to cells. Even relatively hydrophobic pyrene lipids can be used to label cells.
2. The transfer of these lipids is limited by their efflux rate from the donor
membrane. This information should help to develop even more efficient lipid transfer
methods.
3. The developed imaging methods significantly facilitate quantitative imaging
of pyrene lipids in living cells.
4. The use of lipid analogues having similar hydrophobicity as the natural
phospholipids is important in phospholipid trafficking studies. Otherwise there is a danger
of obtaining misleading data.
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